GLP-1S — Research Peptide
Description
GLP-1S is a proprietary code-designated peptide analogue within the incretin receptor research class.
It has been studied for its activity at the GLP receptor site, supporting investigations into receptor-mediated signaling that influences glucose regulation and metabolic pathway modulation.
In experimental models, this receptor activity has been associated with modulation of glycemic signaling dynamics and adaptive cellular response mechanisms.
GLP-1S is of growing interest in in-vitro research focused on incretin receptor pharmacology and integrated metabolic signaling pathways.
This material is supplied in lyophilized powder form and intended strictly for in-vitro and laboratory research by qualified professionals.
Specifications
- Form: Lyophilized peptide (powder)
- Purity: ≥ 99% (HPLC verified)
- Storage: −20 °C or below; avoid repeated freeze–thaw cycles
- Solvent: Reconstitute with sterile bacteriostatic water (for research use only)
- Molecular Class: GLP receptor agonist analogue
- CAS Reference: Available upon request
Available Variants
- 10 mg vial
Disclaimer
For research use only. Not for human or animal consumption, therapeutic use, or diagnostic procedures.
By purchasing, the customer confirms they are a qualified researcher and understands the intended use.

